MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
The Cath Lab Cliff: A Warning Sign of a System in Fracture
By Joel Sauer, MBA, and Ana A. Mercurio-Pinto, MHM
Advancing Structural Heart Care With Automation and AI
With Haytham Allaham, MD; Megan Coylewright, MD, MPH, FACC, FSCAI; and Mukta Srivastava, MD
High-Risk Atherosclerotic Plaque: Defining Features and Assessment on Imaging
By Priyadarshini Dixit, MD; Sierra Fleming, MD; and Olga Toleva, MD, MPH
Management of Nodular Coronary Calcium
By Yasser M. Sammour, MD, MSc; Andrew Murphy, MD; Robert Nicholson, MD; and Pratik Sandesara, MD
Severe Calcifications in Chronic Total Occlusions
By Jiho Han, MD, MS, and Margaret McEntegart, MD, PhD